Market Leading Xcelodose™ Expertise
Xcelience, the market leader for API in capsule and powder-in-capsule (PIC) services, is proud to offer a defined program Using Xcelodose® Technology to help clients do more with less.
Join our API into Capsule Technical Users Group on LinkedIn
Xcelience Benefits Of leveraging Xcelience Expertise with Xcelodose® Technology
- Market Leading Expertise – Having worked with more than 100 APIs and 130 batches, Xcelience has more experience with API in capsule services with Xcelodose® precision powder micro-dosing systems than other contract research organization.
- Global Capacity – Xcelience provides access to four of Capsugel®’s Xcelodose® precision powder micro-dosing systems to ensure timely study initiation, provide reliable back-up technology, and maximize client convenience by enabling clinical supply manufacture in close proximity to clinical sites.
- Preparedness – To minimize downtime, Xcelience maintains a full inventory of change parts that accommodate all capsule sizes and instrument spare parts.
Defined Program Using Xcelodose® technology
Xcelience has created a defined program using the Xcelodose® 600 and 600 S systems to provide a faster, more cost effective path to Phase I studies. Xcelience API into capsule services enable greater flexibility in dosing for the clinic without resulting loss in quality. The system can accommodate small or large quantity batches, and provides the ability to adjust the dose with minimal loss of active pharmaceutical ingredient (API).
Xcelodose® is a registered trademark of Capsugel® BVBA. Reference Links for Capsugel’s Xcelodose® Technology: Xcelodose® 600 Features, Xcelience First North-American CRO to Purchase an Xcelodose® 600, Xcelodose® 600 Case Study featured in Tablets & Capsules (March, 2007)
